Climb Bio (CLYM) Earnings Date & Reports

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CLYM is expected to report earnings to fall 18.16% to -15 cents per share on March 09

Q4'25

Est.

$-0.16

Q3'25

Missed

by $0.04

Q2'25

Beat

by $0.05

Q1'25

Missed

by $0.16

The last earnings report on November 06 showed earnings per share of -18 cents, missing the estimate of -14 cents. With 222.23K shares outstanding, the current market capitalization sits at 130.91M.

View a ticker or compare two or three

Compare

CLYM

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CLYM showed earnings on November 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading for CLYM

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details